Migraines affect millions of Americans, and are among the most poorly treated diagnoses due to limitations in medication and interventional techniques. Patients failing traditional migraine abortants and preventative medications have been left with few options.

With the advent of Aimovig, this is changing. Restore Medical Partners utilizes Aimovig, an injectable medication, to provide long-term migraine relief for patients. Aimovig has been proven in clinical studies to reduce the average number of “migraine days” suffered by patients, and can be administered with a simple injection in the office.